↓ Skip to main content

Outcomes of infliximab dose escalation in patients with rheumatoid arthritis

Overview of attention for article published in Clinical Rheumatology, May 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
2 news outlets

Readers on

mendeley
3 Mendeley
Title
Outcomes of infliximab dose escalation in patients with rheumatoid arthritis
Published in
Clinical Rheumatology, May 2019
DOI 10.1007/s10067-019-04543-z
Pubmed ID
Authors

Stanley B. Cohen, Joel M. Kremer, Kimberly J. Dandreo, George W. Reed, Robert Magner, Ying Shan, Shelly Kafka, Raphael J. DeHoratius, Lorie Ellis, Dennis Parenti

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 67%
Student > Master 1 33%
Readers by discipline Count As %
Unspecified 2 67%
Medicine and Dentistry 1 33%

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 May 2019.
All research outputs
#1,132,287
of 13,777,184 outputs
Outputs from Clinical Rheumatology
#95
of 1,776 outputs
Outputs of similar age
#35,385
of 252,569 outputs
Outputs of similar age from Clinical Rheumatology
#7
of 49 outputs
Altmetric has tracked 13,777,184 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,776 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 252,569 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.